Support for Industry Focus comes from our friends at Rocket Mortgage by Quicken Loans.

You're confident when it comes to your work in life.

Rocket Mortgage gives you that same confidence when it comes to refinancing your existing mortgage

or buying a home.

It lets you understand all the details so you can be confident

that you're getting the right mortgage for you. Go to rocket mortgage.com slash fool.

Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.

It's Wednesday, December 12th.

I'm your host Christine Harajus and I'm joined via Skype by fool.

Health Care Expert Todd Campbell.

On today's show, we'll be recapping one of the

most important health care conferences of the year, Ash, which is an acronym

for the American Society of Hematology, which has 17,000 members across 100 countries.

It's a very big deal.

Hematology is the study of blood diseases

and investors, doctors, researchers, and patients alike

all look forward to hearing the latest from companies like

blood cancer heavy weight cell gene, Karti specialist Juno therapeutics, and Gene Therapy pioneer

Spark Therapeutics. We'll take a look at each of these companies presentations from the conference

starting with the data release from Selgene and its partner Bluebird Bio in

multiple Myeloma but before we do that we're going to talk a lot about Karti therapy today.

And in this year's Ash presentations, it was very clear that that is the next generation of

...